Company · CIK 1799448

# Aligos Therapeutics, Inc.

| CIK | [1799448](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001799448) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | ALGS (Nasdaq) |
| First annual or quarterly report | 2020-11-25 |

## Offerings

 6 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-286168 | Shelf Effective | 2025-03-27 | 2025-04-03 | 2 |
| 333-283041 | Shelf Effective | 2024-11-06 | 2024-11-18 | 2 |
| 333-275636 | Shelf Effective | 2023-11-17 | 2023-11-27 | 2 |
| 333-260774 | Shelf Effective | 2021-11-04 | 2021-11-19 | 2 |
| 333-257466 | Registered company Final prospectus | 2021-06-28 | 2021-07-01 | 3 |
| 333-249077 | IPO Final prospectus | 2020-09-25 | 2020-10-19 | 4 |

## Filings

 17

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2025-04-03 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1799448/999999999525000975/9999999995-25-000975-index.htm) Declared effective | 333-286168 | 9999999995-25-000975 |
| 2025-03-27 | [S-3](https://www.sec.gov/Archives/edgar/data/1799448/000119312525065499/0001193125-25-065499-index.htm) Shelf registered | 333-286168 | 0001193125-25-065499 |
| 2024-11-18 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1799448/999999999524003508/9999999995-24-003508-index.htm) Declared effective | 333-283041 | 9999999995-24-003508 |
| 2024-11-06 | [S-3](https://www.sec.gov/Archives/edgar/data/1799448/000119312524252199/0001193125-24-252199-index.htm) Shelf registered | 333-283041 | 0001193125-24-252199 |
| 2023-11-27 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1799448/999999999523003451/9999999995-23-003451-index.htm) Declared effective | 333-275636 | 9999999995-23-003451 |
| 2023-11-17 | [S-3](https://www.sec.gov/Archives/edgar/data/1799448/000119312523279833/0001193125-23-279833-index.htm) Shelf registered | 333-275636 | 0001193125-23-279833 |
| 2021-11-19 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1799448/999999999521004423/9999999995-21-004423-index.htm) Declared effective | 333-260774 | 9999999995-21-004423 |
| 2021-11-04 | [S-3](https://www.sec.gov/Archives/edgar/data/1799448/000119312521320316/0001193125-21-320316-index.htm) Shelf registered | 333-260774 | 0001193125-21-320316 |
| 2021-07-01 | [424B4](https://www.sec.gov/Archives/edgar/data/1799448/000119312521206345/0001193125-21-206345-index.htm) Final prospectus | 333-257466 | 0001193125-21-206345 |
| 2021-06-30 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1799448/999999999521002615/9999999995-21-002615-index.htm) Declared effective | 333-257466 | 9999999995-21-002615 |
| 2021-06-28 | [S-1](https://www.sec.gov/Archives/edgar/data/1799448/000119312521201893/0001193125-21-201893-index.htm) Registration filed | 333-257466 | 0001193125-21-201893 |
| 2021-06-04 | [DRS](https://www.sec.gov/Archives/edgar/data/1799448/000095012321007570/0000950123-21-007570-index.htm) Draft made public | 377-04970 | 0000950123-21-007570 |
| 2020-10-19 | [424B4](https://www.sec.gov/Archives/edgar/data/1799448/000119312520272151/0001193125-20-272151-index.htm) Final prospectus | 333-249077 | 0001193125-20-272151 |
| 2020-10-15 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1799448/999999999520002863/9999999995-20-002863-index.htm) Declared effective | 333-249077 | 9999999995-20-002863 |
| 2020-10-09 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1799448/000119312520267346/0001193125-20-267346-index.htm) Amendment | 333-249077 | 0001193125-20-267346 |
| 2020-09-25 | [S-1](https://www.sec.gov/Archives/edgar/data/1799448/000119312520254760/0001193125-20-254760-index.htm) Registration filed | 333-249077 | 0001193125-20-254760 |
| 2020-08-26 | [DRS](https://www.sec.gov/Archives/edgar/data/1799448/000095012320009341/0000950123-20-009341-index.htm) Draft made public | 377-03456 | 0000950123-20-009341 |

[All filings of this company](https://equitycapital.markets/filings?cik=1799448) · [CSV](https://equitycapital.markets/filings.csv?cik=1799448)

---
Source page: https://equitycapital.markets/company/1799448 · Data: U.S. SEC EDGAR · CC BY 4.0